Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US-based clinical research organization PRA has acquired ClinStar, a clinical research organization managing Phase I-IV clinical research trials, for an undisclosed amount.
Subscribe to our email newsletter
ClinStar provides Phase I-IV clinical research trials and clinical development services to a wide range of pharmaceutical and biotechnology companies in the Russian Federation, Ukraine, Belarus and the Baltic States.
The acquisition also includes ClinStar’s stand-alone clinical trial warehousing and logistics division, IMP Logistics, operating in Russia, Ukraine and Belarus.
After the completion of acquisition, PRA plans to integrate the 300 ClinStar and IMP Logistics employees with successful operational delivery as a primary objective.
PRA president and CEO Colin Shannon said the firm’s acquisition of ClinStar will increase its operations and expertise in Russia and Eastern Europe.
"Their knowledge and experience in this region complements PRA’s overall global reach and infrastructure. We look forward to welcoming ClinStar employees into PRA and combining the expertise of both organizations to benefit both PRA’s and ClinStar’s clients," Shannon added.